U & V Cancure Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.47 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 29.41%
- Profit Growth 60.19%
- Ebitda 64.02%
- Net Worth 11.76%
- Total Assets 57.41%
About U & V Cancure
U & V Cancure Private Limited (UVCPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 May 2009 and has a history of 15 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.47 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Kaushik and Babu Kaushik serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24296DL2009PTC190542
-
Company No.
190542
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 May 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does U & V Cancure Private Limited offer?
U & V Cancure Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Cancer Injection, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Surgical & ICU Equipments, Dialysis Machine, Common Disease Medicines, Antiseptic Mouthwashes, Industrial Chemicals & Supplies.
Who are the key members and board of directors at U & V Cancure?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kaushik
|
Director | 22-May-2009 | Current |
|
Babu Kaushik
|
Director | 17-Apr-2010 | Current |
Financial Performance of U & V Cancure.
U & V Cancure Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.41% increase. The company also saw a substantial improvement in profitability, with a 60.19% increase in profit. The company's net worth Soared by an impressive increase of 11.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of U & V Cancure?
In 2020, U & V Cancure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at U & V Cancure?
Unlock and access historical data on people associated with U & V Cancure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of U & V Cancure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped U & V Cancure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
